NL-OMON28934已完成不适用
A preference trial with rizatriptan 10 mg and ibuprofen 400 mg in migraine patients in the general practice.
未提供0 个研究点目标入组 35 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 35
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. The subject is at least 18 years of age at visit 1;
- •2. The subject has a current history of migraine with or without aura according to the IHS criteria;
排除标准
- •1. Subjects with a history suggestive of ischaemic heart disease (IHD), (e.g. angina pectoris) or any atherosclerotic disease which places them at increased risk of coronary ischaemia;
- •2. Subjects with a history of cerebrovascular accident (CVA) or transient ischaemic attack (TIA);
研究者
相似试验
已完成
不适用
A preference trial with rizatriptan 10 mg and ibuprofen 400 mg in migraine patients in the general practiceNervous System DiseasesMigraineISRCTN18216584Merck Sharp and Dohme BV (MSD) (The Netherlands)35
已完成
不适用
A preference trial with naratriptan 2,5 mg and paracetamol 1000 mg in migraine patients in the general practice.NL-OMON2289340
已完成
3 期
MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029)Migraine HeadacheNCT00897104Organon and Co933
已完成
3 期
Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)Migraine HeadacheNCT00898677Organon and Co1,268
已完成
不适用
A preference trial with naratriptan 2.5 mg and paracetamol 1000 mg in migraine patients in the general practiceNervous System DiseasesMigraineISRCTN57387771eiden University Medical Centre (LUMC) (The Netherlands)40